Discover
NVAX
Novavax, Inc.
7.82
4 x 7.81
8 x 7.82
bid
ask
-
0.07
0.92%
01:33 PM
timesize
| Ytd | 16.33% | |
| 1y | -2.65% |
7.78
day range
8.03
6.20
52 week range
11.97
| Open | 7.93 | Prev Close | 7.89 | Low | 7.78 | High | 8.03 | Mkt Cap | 1.29B |
| Vol | 1.26M | Avg Vol | 4.28M | EPS | -0.89 | P/E | -8.78 | Forward P/E | -12.95 |
| Beta | 2.46 | Short Ratio | 10.00 | Inst. Own | 71.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.73 | 200-d Avg | 8.44 | 1yr Est | 14.00 |
| Income Statement | |||
| Total Revenue | 56.70M | ||
| Revenues (USD) | 56.70M | ||
| Cost of Revenue | 14.25M | ||
| Gross Profit | 42.45M | ||
| Operating Expenses | 97.36M | ||
| Research and Development Expense | 70.69M | ||
| Selling, General and Administrative Expense | 26.67M | ||
| Operating Income | -54.91M | ||
| Interest Expense | 5.69M | ||
| Income Tax Expense | 1.71M | ||
| Net Income | -53.39M | ||
| Net Income Common Stock | -53.39M | ||
| Net Income Common Stock (USD) | -53.39M | ||
| Consolidated Income | -53.39M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -45.99M | ||
| Earning Before Interest & Taxes (USD) | -45.99M | ||
| Weighted Average Shares | 164.57M | ||
| Weighted Average Shares Diluted | 164.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 191.46M | ||
| Cash and Equivalents (USD) | 191.46M | ||
| Investments | 527.88M | ||
| Investments Current | 527.88M | ||
| Trade and Non-Trade Receivables | 18.74M | ||
| Current Assets | 771.10M | ||
| Property, Plant & Equipment Net | 57.98M | ||
| Total Assets | 955.58M | ||
| Debt Current | 4.11M | ||
| Total Debt | 297.32M | ||
| Current Liabilities | 330.57M | ||
| Debt Non-Current | 293.21M | ||
| Total Liabilities | 1.15B | ||
| Accumulated Retained Earnings (Deficit) | -4.63B | ||
| Accumulated Other Comprehensive Income | -7.45M | ||
| Shareholders Equity | -190.71M | ||
| Shareholders Equity (USD) | -190.71M | ||
| Assets Non-Current | 184.48M | ||
| Total Debt (USD) | 297.32M | ||
| Deferred Revenue | 443.33M | ||
| Goodwill and Intangible Assets | 112.54M | ||
| Inventory | 10.01M | ||
| Liabilities Non-Current | 815.71M | ||
| Trade and Non-Trade Payables | 22.94M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.06M | ||
| Net Cash Flow from Financing | 1.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.88M | ||
| Capital Expenditure | -588.00K | ||
| Issuance (Purchase) of Equity Shares | 1.73M | ||
| Issuance (Repayment) of Debt Securities | -526.00K | ||
| Net Cash Flow from Investing | 34.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 35.49M | ||
| Net Cash Flow from Operations | -72.81M | ||
| Effect of Exchange Rate Changes on Cash | -176.00K | ||
| Share Based Compensation | 8.09M | ||